Skip to content

Severe Acute Respiratory Infections (SARI) in Belgium (2011-2020)

Severe Acute Respiratory Infections Surveillance in Belgium (2011-2020, Prior to COVID-19 Pandemic)

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05620953
Acronym
SARIpreSC2
Enrollment
12145
Registered
2022-11-17
Start date
2012-01-20
Completion date
2020-04-02
Last updated
2023-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Influenza Viral Infections, Respiratory Viral Infection, Severe Acute Respiratory Infection

Keywords

sentinel surveillance

Brief summary

The Belgian Severe Acute Respiratory Infections network (BELSARI-net) was implemented during the influenza season 2011-2012 following the recommendations of the World Health Organization (WHO) to monitor severity of influenza viruses in hospitals. The network is composed of 6 hospitals throughout the country, two in each administrative region (Flanders, Wallonia and Brussels-Capital), and operates during the influenza epidemic period (from the last week of December or first/second week of January to the third/last week of April, depending on when influenza virus circulation is detected by the general population, based on the Influenza-like illness (ILI) network of general practitioners). Enrollment is performed for all cases matching the SARI case definition (based on WHO's case definition) and accepting to take part. A respiratory specimen is sampled systematically from each participant, and detailed clinico-epidemiological data, such as information on age, sex, symptoms and potential risk factors such as pregnancy or comorbidities (chronic respiratory diseases, asthma, chronic cardiovascular diseases, renal insufficiency, obesity, diabetes, hepatic or renal insufficiency, immunodeficiency, neuromuscular disease, pregnancy) is also collected. Participants are followed up during hospitalization for the occurrence of complications (detection of pneumonia based on chest radiography, development of acute respiratory distress syndrome (ARDS), requirement for respiratory assistance and/or for extracorporeal membrane oxygenation (ECMO), admission in intensive care unit (ICU)), or death (all-cause death). The current project includes all the samples received by the Belgian National Influenza Centre (NIC) during the influenza seasons 2011-2012 till 2019-2020.

Interventions

DIAGNOSTIC_TESTrespiratory specimen

nasopharyngeal swab or nasal aspiration or broncho-alveolar lavage

Sponsors

Belgian Federal Public Service, Food Chain Safety and Environment
CollaboratorOTHER_GOV
Centre Hospitalier Universitaire Saint Pierre
CollaboratorOTHER
AZ Sint-Jan AV
CollaboratorOTHER
Universitair Ziekenhuis Brussel
CollaboratorOTHER
Grand Hôpital de Charleroi
CollaboratorOTHER
Jessa Hospital
CollaboratorOTHER
Centre Hospitalier Universitaire UCLouvain Namur
CollaboratorOTHER
Sciensano
Lead SponsorOTHER_GOV

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* All pediatric and adult patients admitted to one of the 6 sentinel hospitals during the active surveillance and fulfilling the case definition of acute respiratory infection with onset within the last ten days, with history of fever or measured fever of ≥38°C, with cough and/or dyspnea, and overnight hospitalization.

Exclusion criteria

* nosocomial infection, i.e. symptoms appearing after admission

Design outcomes

Primary

MeasureTime frameDescription
Number of participants positive for influenza viruseswithin 10 days after symptom onsetresult of influenza PCR detection test (typing and subtyping)
Number of participants positive for non-influenza viruseswithin 10 days after symptom onset (only routinely tested since influenza season 2015-2016)results of non-influenza multiplex PCR detection test (16 targets)
Number of participants who died during hospitalizationfrom date of hospital admission until date of death during hospitalization or date of hospital exitalive or dead

Secondary

MeasureTime frameDescription
Number of participants with at least one known risk factoron date of hospital admissionexistence of co-morbidities or known risk factors among a list provided on form
Number of participants who experienced at least one complicationfrom date of hospital admission until date of death during hospitalization or date of hospital exitoccurence of complications (among a list provided on form) during hospitalisation stay

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026